Edited by William Billeaud of Lombard Global, Inc. with Renan Vicentini; information provided by GCC, Porto Alegre  

Teaser – Hospital Group

Opportunity: Total Sale of the Company

Business Presentation

The group, located in the North of Rio Grande do Sul, is focused in the hospital services and clinical analysis ector. The firm also offers corporate and familiar health care, hemodynamic services and chemotherapy. With more than 250 employees –including members in the administrative sector, clinical service and laboratory for clinical analysis – its installations have a modern and pleasant structure for its patients in the two main cities of the South region.

The group’s headquarters is located in a city known for its health services and the company’s facilities represent one of the most highly regarded medical centers in the South region of Brazil. Furthermore, 1.5 million people on average have received medical assistance in this city, its patient base reaching even the neighboring cities in the region, including some in Santa Catarina.

Diagnostic Services   

  • Emergency Room/Ambulatory care service 24 hs
  • Electroencephalography – Vigil and Sleep
  • Upper and Lower Digestive Endoscopy
  • Radiology
  • One and bi-dimensional echocardiography with Doppler
  • Mammography
  • Hemodynamics
  • Ultrasound
  • Eco Doppler Carotid Examination
  • Laboratory for Clinical Analysis
  • Resting Electrocardiogram and Ergography

Structure

Head office (headquarter city) 

Located in the city center 

3 buildings, amounting to 10.252 m² of constructed area and an expansion project 

Laboratory of the company for clinical analysis with cut-edging equipment 

Hospital beds for admissions: 110 

Hospital ICU beds – Adults : 8 

Neonatal ICU beds: 7 

Surgical wing: 6 rooms

Branch office (another city) 

Building of the company measuring 1.872 m²

Employees

Administration          88
Clinical Services       163
Laboratory              13
___________________________________
TOTAL 264

Revenue growth

2012 E   $12.624 million USD

2011        $11.4785 USD

2010        $10.448 million USD

2009        $9.0024 million USD

EBITDA Margin

2012 E    14.9%

2011         14%

2010        13%

2009        14.3%

Business Valuation

$20-50 million BRD/$10-$25 million USD

_________________________________________________________________________________________________________________________________

Teaser – Orthopedic Implants and Medical Equipment

Opportunity: Sale of the company as a whole

Business Presentation

Based in the city of São Leopoldo, in the metropolitan region of Porto Alegre, the Company utilizes advanced technology for the production of orthopedic implants and various hospital-medical items, with focus on products to be used for bone cementation and implants in the vertebral column.

The Company is showing rapid growth; it has increased its revenue at an average annual rate of 50% along the last three years. The production structure and the employee headcount doubled in that period.

The expectations for Company growth, together with the current performance of the sector (hospital-medical inputs), assure the enterprise as being an excellent investment opportunity.

Additional Information

The enterprise’s field of activity covers hospital markets in several Brazilian states. The sales are made directly to hospitals, through registered health insurance companies, or also to distributors throughout the country.

The company maintains a solid network of registered partnerships, encouraging the attendance of a large customer base. Regarding licenses and certifications, its products are inspected regularly by competent regulatory authorities. Driven by the expansion of its customer network, by the growth of the Brazilian medical hospital supplies and by the access to health plans, the firm’s results show a strong evolution. In addition, to allow sustainable growth, the company plans to invest about R$ 2 million over the next years.

Revenue Growth

2012 est.    $6.285 million USD (+30%)

2011             $4.6248 million USD (+35%)

2010            $2.7504 million USD (+69%)

2009           $18663 million USD (+49%)

EBITDA Margin

2013E (+55.5%)

2012E (+55.3%)

2011E (+54.4%)

Business Valuation

$15 million BRD/ $7.360 million USD